In a different study on prostate cancer, daidzein and genistein inhibited cancer cell growth and promoted apoptosis by altering the methylation status of several genes involved in the NF-κB and p53 pathways in prostate cancer cells (171). The gene discussed is TP53; the disease is prostate carcinoma.